Return On Equity of Protara Therapeutics, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Protara Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Protara Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -35%, a 37% increase year-over-year.
  • Protara Therapeutics, Inc. annual Return On Equity for 2024 was -45%, a 10% increase from 2023.
  • Protara Therapeutics, Inc. annual Return On Equity for 2023 was -50%, a 1.6% decline from 2022.
  • Protara Therapeutics, Inc. annual Return On Equity for 2022 was -49%, a 81% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Protara Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -35% +21% +37% 01 Jul 2025 30 Sep 2025
Q2 2025 -37% +18% +33% 01 Apr 2025 30 Jun 2025
Q1 2025 -36% +22% +38% 01 Jan 2025 31 Mar 2025
Q4 2024 -45% +5% +10% 01 Oct 2024 31 Dec 2024
Q3 2024 -56% +21% +27% 01 Jul 2024 30 Sep 2024
Q2 2024 -55% +9% +13% 01 Apr 2024 30 Jun 2024
Q1 2024 -59% -5% -10% 01 Jan 2024 31 Mar 2024
Q4 2023 -50% -1% -1.6% 01 Oct 2023 31 Dec 2023
Q3 2023 -77% -52% -210% 01 Jul 2023 30 Sep 2023
Q2 2023 -64% -38% -149% 01 Apr 2023 30 Jun 2023
Q1 2023 -53% -27% -99% 01 Jan 2023 31 Mar 2023
Q4 2022 -49% -22% -81% 01 Oct 2022 31 Dec 2022
Q3 2022 -25% 0% +0.16% 01 Jul 2022 30 Sep 2022
Q2 2022 -26% -3% -13% 01 Apr 2022 30 Jun 2022
Q1 2022 -27% -4% -15% 01 Jan 2022 31 Mar 2022
Q4 2021 -27% -1% -3.1% 01 Oct 2021 31 Dec 2021
Q3 2021 -25% +10% +29% 01 Jul 2021 30 Sep 2021
Q2 2021 -23% +50% +69% 01 Apr 2021 30 Jun 2021
Q1 2021 -23% +78% +77% 01 Jan 2021 31 Mar 2021
Q4 2020 -26% +873% +97% 01 Oct 2020 31 Dec 2020
Q3 2020 -35% +372% +91% 01 Jul 2020 30 Sep 2020
Q2 2020 -72% +73% +50% 01 Apr 2020 30 Jun 2020
Q1 2020 -101% +10% +8.7% 01 Jan 2020 31 Mar 2020
Q4 2019 -899% -801% -819% 01 Oct 2019 31 Dec 2019
Q3 2019 -407% -334% -455% 01 Jul 2019 30 Sep 2019
Q2 2019 -146% -56% -63% 01 Apr 2019 30 Jun 2019
Q1 2019 -110% -22% -24% 01 Jan 2019 31 Mar 2019
Q4 2018 -98% -10% -12% 01 Oct 2018 31 Dec 2018
Q3 2018 -73% +16% +18% 01 Jul 2018 30 Sep 2018
Q2 2018 -89% -17% -24% 01 Apr 2018 30 Jun 2018
Q1 2018 -89% -20% -30% 01 Jan 2018 31 Mar 2018
Q4 2017 -88% -28% -47% 01 Oct 2017 31 Dec 2017
Q3 2017 -89% -38% -73% 01 Jul 2017 30 Sep 2017
Q2 2017 -72% -29% -66% 01 Apr 2017 30 Jun 2017
Q1 2017 -68% -33% -93% 01 Jan 2017 31 Mar 2017
Q4 2016 -60% -30% -98% 01 Oct 2016 31 Dec 2016
Q3 2016 -52% -41% -401% 01 Jul 2016 30 Sep 2016
Q2 2016 -43% -18% -69% 01 Apr 2016 30 Jun 2016
Q1 2016 -35% 01 Jan 2016 31 Mar 2016
Q4 2015 -30% 01 Oct 2015 31 Dec 2015
Q3 2015 -10% 01 Jul 2015 30 Sep 2015
Q2 2015 -26% 01 Apr 2015 30 Jun 2015

Protara Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -45% +5% +10% 01 Jan 2024 31 Dec 2024
2023 -50% -1% -1.6% 01 Jan 2023 31 Dec 2023
2022 -49% -22% -81% 01 Jan 2022 31 Dec 2022
2021 -27% -1% -3.1% 01 Jan 2021 31 Dec 2021
2020 -26% +873% +97% 01 Jan 2020 31 Dec 2020
2019 -899% -801% -819% 01 Jan 2019 31 Dec 2019
2018 -98% -10% -12% 01 Jan 2018 31 Dec 2018
2017 -88% -28% -47% 01 Jan 2017 31 Dec 2017
2016 -60% -30% -98% 01 Jan 2016 31 Dec 2016
2015 -30% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.